Back to Explorer

21CFR807.97

§ 807.97 Misbranding by reference to premarket notification.

Regulation Text

Submission of a premarket notification in accordance with this subpart, and a subsequent determination by the Commissioner that the device intended for introduction into commercial distribution is substantially equivalent to a device in commercial distribution before May 28, 1976, or is substantially equivalent to a device introduced into commercial distribution after May 28, 1976, that has subsequently been reclassified into class I or II, does not in any way denote official approval of the device. Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding.

Authority

21 U.S.C. 321,331,351,352,360,360c,360e,360e-4,360i,360j,360bbb-8b,371,374,379k-1,381,393;42 U.S.C. 264,271.

View in Graph Explorer

Related Guidelines (2)

21CFR807.97 — § 807.97 Misbranding by reference to premarket notification. | CFR Explorer | BioRegHub